FIELD: medicine; pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition in the form of a sustained release tablet containing from 100 to 600 mg of Pirfenidone (PFD), in which the drug is bioavailable for an extended period of time lasting 12 hours from the administration thereof.
EFFECT: present invention provides a higher therapeutic effectiveness compared with other pharmaceutical forms of pirfenidone for oral administration.
8 cl, 6 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING FORMATION OF CAPSULAR CONTRACTURE AFTER ENDOPROSTHETICS OF MAMMARY GLANDS | 2015 |
|
RU2616211C1 |
METHOD FOR PREVENTING AND TREATING CAPSULE CONTRACTURES | 1995 |
|
RU2129029C1 |
METHOD OF AUTOADIPOTRANSPLANTATION COMBINED WITH AUGMENTATION MAMMOPLASTY | 2022 |
|
RU2817808C1 |
METHOD FOR ELIMINATION OF BREAST IMPLANT RIPPLING | 2023 |
|
RU2818127C1 |
METHOD OF PREPECTORAL RECONSTRUCTION OF MAMMARY GLANDS AFTER SKIN-PRESERVING MASTECTOMY | 2022 |
|
RU2802144C1 |
MEDICINAL PRODUCT FOR OPTIMISING THE SURVIVAL OF A SILICONE IMPLANT AFTER RECONSTRUCTIVE-REPARATIVE BREAST SURGERY | 2022 |
|
RU2788259C1 |
METHOD FOR PREPECTORAL RECONSTRUCTION WITH IMPLANT WITH TEXTURED COATING FOR SMALL AND MEDIUM-SIZED MAMMARY GLANDS, “PINCH TEST” MORE THAN 1 CM, II-III DEGREE PTOSIS | 2020 |
|
RU2756184C2 |
METHOD OF SURGICAL CORRECTION OF ROTATION OF ENDOMAMMARY ANATOMICAL SILICONE IMPLANT | 2022 |
|
RU2804252C1 |
METHOD OF AUGMENTATION MAMMOPLASTY | 2017 |
|
RU2675019C1 |
METHOD FOR STRENGTHENING A LOWER SLOPE OF THE FORMED MAMMARY GLAND IN RECONSTRUCTIVE AND PLASTIC SURGERY IN BREAST CANCER PATIENTS | 2019 |
|
RU2722351C2 |
Authors
Dates
2019-03-15—Published
2012-07-13—Filed